Type | Number of adverse reactions | References | |
---|---|---|---|
Treatment group | Control group | ||
Nausea and vomiting | 2 | 3 | Chai et al., 2017. |
Rhinobyon | 1 | 3 | Chai et al., 2017. |
Orthostatic hypotension | 1 | 2 | Chai et al., 2017. |
Tachycardia | 0 | 2 | Chai et al., 2017. |
Dry cough | 7 | 2 | Liang, 2016; Liu et al., 2017; Lu et al., 2014; Mei 2018; Song et al., 2017. |
Hypotension | 5 | 1 | Liang, 2016; Liu et al., 2017; Lu et al., 2014; Mei 2018; Song et al., 2017. |
Abnormal liver function | 1 | 2 | Zhang et al., 2018. |
Urticaria | 2 | 2 | Zhang et al., 2018. |
Fever | 1 | 2 | Zhang et al., 2018. |
Gastrointestinal reaction | 1 | 1 | Zhang et al., 2018. |
Total event | 21 | 20 | Â |
Incidence rate | 2.31% (21/909) | 2.21% (20/906) | Â |